Loh, K. P., Sanapala, C., Janelsins, M., Klepin, H. D., Schnall, R., Culakova, E., Sohn, M. B., Vertino, P., Susiarjo, M., Jensen-Battaglia, M., Becker, M. W., Liesveld, J., Mendler, J. H., Huselton, E., Lin, P.-J., & Mustian, K. (2022). Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2). Journal of Geriatric Oncology, 13(4), 545–553. https://doi.org/10.1016/j.jgo.2021.12.011

Mukherjee, S., Ali, A. M., Murty, V. V., & Raza, A. (2022). Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells. Medical Oncology, 39(6). https://doi.org/10.1007/s12032-022-01652-9

Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022). Deciphering the acetylation code of p53 in transcription regulation and tumor suppression. Oncogene, 41(22), 3039–3050. https://doi.org/10.1038/s41388-022-02331-9

Rehnberg, J., Ludvigsson, J. F., Carrero, J.-J., & Emilsson, L. (2021). Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study. Nephrology Dialysis Transplantation, 37(4), 749–759. https://doi.org/10.1093/ndt/gfab322

Mazza, G. L., Petersen, M. M., Ginos, B., Langlais, B. T., Heon, N., Gounder, M. M., Mahoney, M. R., Zoroufy, A. J., Schwartz, G. K., Rogak, L. J., Thanarajasingam, G., Basch, E., & Dueck, A. C. (2021). Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2. Quality of Life Research, 31(4), 1069–1080. https://doi.org/10.1007/s11136-021-02968-1

Koehne de González, A., Mansukhani, M. M., Fernandes, H., & Hsiao, S. J. (2022). Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing. Cancer Genetics, 262–263, 47–52. https://doi.org/10.1016/j.cancergen.2021.12.010

Batra, J., DeFilippis, E. M., Golob, S., Clerkin, K., Topkara, V. K., Habal, M. V., Restaino, S., Griffin, J., Hi Lee, S., Latif, F., Farr, M. A., Sayer, G., Raikelkar, J., & Uriel, N. (2022). Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies. Circulation: Heart Failure, 15(4). https://doi.org/10.1161/circheartfailure.121.008968

Diamond, J. R., Boni, V., Lim, E., Nowakowski, G., Cordoba, R., Morillo, D., Valencia, R., Genvresse, I., Merz, C., Boix, O., Frigault, M. M., Greer, J. M., Hamdy, A. M., Huang, X., Izumi, R., Wong, H., & Moreno, V. (2022). First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. Clinical Cancer Research, 28(7), 1285–1293. https://doi.org/10.1158/1078-0432.ccr-21-3617

Ronaldson-Bouchard, K., Baldassarri, I., Tavakol, D. N., Graney, P. L., Samaritano, M., Cimetta, E., & Vunjak-Novakovic, G. (2022). Engineering complexity in human tissue models of cancer. Advanced Drug Delivery Reviews, 184, 114181. https://doi.org/10.1016/j.addr.2022.114181

Zheng, L., Luo, C., Yang, N., Pei, H., Ji, M., Shu, Y., Zhang, Z., Dong, S., Wang, X., Li, X., Zhang, W., Wang, Y., Li, B., Hei, T. K., Zhou, G., & Chang, L. (2022). Ionizing radiation-induced long noncoding RNA CRYBG3 regulates YAP/TAZ through mechanotransduction. Cell Death & Disease, 13(3). https://doi.org/10.1038/s41419-022-04650-x

Avutu, V., Monga, V., Mittal, N., Saha, A., Andolina, J. R., Bell, D. E., Fair, D. B., Flerlage, J. E., Frediani, J. N., Heath, J. L., Kahn, J. M., Reichek, J. L., Super, L., Terao, M. A., Freyer, D. R., & Roth, M. E. (2022). Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children’s Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncology Practice, 18(3), 224–231. https://doi.org/10.1200/op.21.00554

Schmidt, A. L., Labaki, C., Hsu, C.-Y., Bakouny, Z., Balanchivadze, N., Berg, S. A., Blau, S., Daher, A., El Zarif, T., Friese, C. R., Griffiths, E. A., Hawley, J. E., Hayes-Lattin, B., Karivedu, V., Latif, T., Mavromatis, B. H., McKay, R. R., Nagaraj, G., Nguyen, R. H., … Warner, J. L. (2022). COVID-19 vaccination and breakthrough infections in patients with cancer. Annals of Oncology, 33(3), 340–346. https://doi.org/10.1016/j.annonc.2021.12.006

Kochanek, M., Kochanek, J., Böll, B., Eichenauer, D. A., Beutel, G., Bracht, H., Braune, S., Eisner, F., Friesecke, S., Günther, U., Heinz, G., Hallek, M., Karagiannidis, C., Kluge, S., Kogelmann, K., Lebiedz, P., Lepper, P. M., Liebregts, T., Lueck, C., … Shimabukuro-Vornhagen, A. (2022). Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis. Intensive Care Medicine, 48(3), 332–342. https://doi.org/10.1007/s00134-022-06635-y

Maniar, A., Haslam, A., & Prasad, V. (2022). Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours. European Journal of Cancer, 164, 95–104. https://doi.org/10.1016/j.ejca.2022.01.006

Shirazian, S., Starakiewicz, P., & Latcha, S. (2021). Cancer Screening in End-Stage Kidney Disease. Advances in Chronic Kidney Disease, 28(5), 502-508.e1. https://doi.org/10.1053/j.ackd.2021.09.006

Powers, J. A., & Chio, I. I. C. (2022). Softening redox homeostasis in cancer cells. Nature Cell Biology, 24(2), 133–134. https://doi.org/10.1038/s41556-022-00845-8

Meric-Bernstam, F., Sweis, R. F., Hodi, F. S., Messersmith, W. A., Andtbacka, R. H. I., Ingham, M., Lewis, N., Chen, X., Pelletier, M., Chen, X., Wu, J., Dubensky, T. W., McWhirter, S. M., Müller, T., Nair, N., & Luke, J. J. (2021). Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research, 28(4), 677–688. https://doi.org/10.1158/1078-0432.ccr-21-1963

Kishore, S. A., Bajwa, R., Van Doren, L., Wilkins, C., & O’Sullivan, G. J. (2022). Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population. Current Oncology Reports, 24(3), 351–362. https://doi.org/10.1007/s11912-022-01191-6

Menolfi, D., & Zha, S. (2021). Targeting BRCA-mutated tumors in mitosis. Nature Cancer, 2(12), 1296–1297. https://doi.org/10.1038/s43018-021-00293-7

Shi, D. D., Guo, J. A., Hoffman, H. I., Su, J., Mino-Kenudson, M., Barth, J. L., Schenkel, J. M., Loeffler, J. S., Shih, H. A., Hong, T. S., Wo, J. Y., Aguirre, A. J., Jacks, T., Zheng, L., Wen, P. Y., Wang, T. C., & Hwang, W. L. (2022). Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. The Lancet Oncology, 23(2), e62–e74. https://doi.org/10.1016/s1470-2045(21)00596-9

Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., Tanoli, Z., Jafari, M., Wan, F., Li, S., Xiong, Y., Duran-Frigola, M., Bertoni, M., Badia-i-Mompel, P., Mateo, L., … Califano, A. (2022). A community challenge for a pancancer drug mechanism of action inference from perturbational profile data. Cell Reports Medicine, 3(1), 100492. https://doi.org/10.1016/j.xcrm.2021.100492

Schöffski, P., Tan, D. S. W., Martín, M., Ochoa-de-Olza, M., Sarantopoulos, J., Carvajal, R. D., Kyi, C., Esaki, T., Prawira, A., Akerley, W., De Braud, F., Hui, R., Zhang, T., Soo, R. A., Maur, M., Weickhardt, A., Krauss, J., Deschler-Baier, B., Lau, A., … Hong, D. S. (2022). Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. Journal for ImmunoTherapy of Cancer, 10(2), e003776. https://doi.org/10.1136/jitc-2021-003776

Hillyer, G. C., Nazareth, M., Lima, S., Schmitt, K. M., Reyes, A., Fleck, E., Schwartz, G. K., & Terry, M. B. (2021). E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk. Journal of Community Health, 47(1), 94–100. https://doi.org/10.1007/s10900-021-01027-7

Liu, Y., & Gu, W. (2022). p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death & Differentiation, 29(5), 895–910. https://doi.org/10.1038/s41418-022-00943-y

Zhang, H. (2022). Cancer Pain Management—New Therapies. Current Oncology Reports, 24(2), 223–226. https://doi.org/10.1007/s11912-021-01166-z

Kuo, C.-C., Balakrishnan, P., Gribble, M. O., Best, L. G., Goessler, W., Umans, J. G., & Navas-Acien, A. (2022). The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study. Environment International, 159, 107029. https://doi.org/10.1016/j.envint.2021.107029

Christin, J. R., & Shen, M. M. (2022). Modeling tumor plasticity in organoid models of human cancer. Trends in Cancer, 8(3), 161–163. https://doi.org/10.1016/j.trecan.2021.12.004

Abbasian Ardakani, A., Bureau, N. J., Ciaccio, E. J., & Acharya, U. R. (2022). Interpretation of radiomics features–A pictorial review. Computer Methods and Programs in Biomedicine, 215, 106609. https://doi.org/10.1016/j.cmpb.2021.106609

Hawley, J. E., Sun, T., Chism, D. D., Duma, N., Fu, J. C., Gatson, N. T. N., Mishra, S., Nguyen, R. H., Reid, S. A., Serrano, O. K., Singh, S. R. K., Venepalli, N. K., Bakouny, Z., Bashir, B., Bilen, M. A., Caimi, P. F., Choueiri, T. K., Dawsey, S. J., Fecher, L. A., … Stratton, C. (2022). Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Network Open, 5(1), e2142046. https://doi.org/10.1001/jamanetworkopen.2021.42046

Tan, A. R., Chan, N., Kiesel, B. F., Stein, M. N., Moss, R. A., Malhotra, J., Aisner, J., Shah, M., Gounder, M., Lin, H., Kane, M. P., Lin, Y., Ji, J., Chen, A., Beumer, J. H., & Mehnert, J. M. (2021). A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies. Cancer Chemotherapy and Pharmacology, 89(1), 49–58. https://doi.org/10.1007/s00280-021-04350-x

Heaney, M. L. (2022). Can the treatment of myeloproliferative neoplasms be both good and bad for you? The Lancet Haematology, 9(1), e3–e4. https://doi.org/10.1016/s2352-3026(21)00371-9

Ayton, S. G., Pavlicova, M., Robles-Espinoza, C. D., Tamez Peña, J. G., & Treviño, V. (2022). Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis. Genetics in Medicine, 24(1), 15–25. https://doi.org/10.1016/j.gim.2021.09.006

Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., Bacher, P., Bari, S., Barnaba, V., Barros‐Martins, J., Baumjohann, D., Beccaria, C. G., Bernardo, D., Boardman, D. A., Borger, J., … Yang, J. (2021). Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). European Journal of Immunology, 51(12), 2708–3145. Portico. https://doi.org/10.1002/eji.202170126

Robinson, J. R. M., Beebe‐Dimmer, J. L., Schwartz, A. G., Ruterbusch, J. J., Baird, T. E., Pandolfi, S. S., Hastert, T. A., Quinn, J. W., & Rundle, A. G. (2021). Neighborhood walkability and body mass index in African American cancer survivors: The Detroit Research on Cancer Survivors study. Cancer, 127(24), 4687–4693. Portico. https://doi.org/10.1002/cncr.33869

Unger, J. M., Beauchemin, M., & Hershman, D. L. (2021). Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years. Cancer, 127(24), 4574–4584. Portico. https://doi.org/10.1002/cncr.33855

Cable, J., Pei, D., Reid, L. M., Wang, X. W., Bhatia, S., Karras, P., Melenhorst, J. J., Grompe, M., Lathia, J. D., Song, E., Kuo, C. J., Zhang, N., White, R. M., Ma, S. K., Ma, L., Chin, Y. R., Shen, M. M., Ng, I. O. L., Kaestner, K. H., … Weissman, I. L. (2021). Cancer stem cells: advances in biology and clinical translation—a Keystone Symposia report. Annals of the New York Academy of Sciences, 1506(1), 142–163. Portico. https://doi.org/10.1111/nyas.14719

Houghton, L. C., Gibbons, M. P., Shekelle, J., Oakley-Girvan, I., Watterson, J. L., Magsamen-Conrad, K., Jones, C., & Gokal, K. (2021). Free Time For Wellness: a co-designed intervention utilizing social networks to encourage physical activity for cancer prevention among low resourced mothers. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11775-9

Wang, Z., Fan, X., Shen, Y., Pagadala, M. S., Signer, R., Cygan, K. J., Fairbrother, W. G., Carter, H., Chung, W. K., & Huang, K. (2021). Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes. Genome Medicine, 13(1). https://doi.org/10.1186/s13073-021-00964-1

Koleck, T. A., Topaz, M., Tatonetti, N. P., George, M., Miaskowski, C., Smaldone, A., & Bakken, S. (2021). Characterizing shared and distinct symptom clusters in common chronic conditions through natural language processing of nursing notes. Research in Nursing & Health, 44(6), 906–919. Portico. https://doi.org/10.1002/nur.22190

Takvorian, S. U., Bekelman, J., Beidas, R. S., Schnoll, R., Clifton, A. B. W., Salam, T., Gabriel, P., Wileyto, E. P., Scott, C. A., Asch, D. A., Buttenheim, A. M., Rendle, K. A., Chaiyachati, K., Shelton, R. C., Ware, S., Chivers, C., Schuchter, L. M., Kumar, P., Shulman, L. N., … Parikh, R. B. (2021). Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial. Implementation Science, 16(1). https://doi.org/10.1186/s13012-021-01156-6

Harkenrider, M. M., Albuquerque, K., Brown, D., Kamrava, M., King, M., Mourtada, F., Orio, P., Patel, R., Price, M., Rassiah, P., Solanki, A. A., Small, W., & Schechter, N. R. (2021). ACR–ABS–ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. Brachytherapy, 20(6), 1071–1082. https://doi.org/10.1016/j.brachy.2021.08.009

Roth, M., Beauchemin, M., Kahn, J. M., & Bleyer, A. (2021). Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults. Cancer Medicine, 10(21), 7620–7628. Portico. https://doi.org/10.1002/cam4.4292

Sasse, P., Bergmann, A., Afonso, W., Ladas, E. J., & Ferman, S. (2021). Malnutrition at diagnosis and throughout therapy in pediatric patients with solid tumors: A single‐institution study in a developing country. Pediatric Blood & Cancer, 68(11). Portico. https://doi.org/10.1002/pbc.29317

Taglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J.-W., Wu-Baer, F., Baer, R., Costanzo, V., & Ciccia, A. (2021). REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Molecular Cell, 81(19), 4008-4025.e7. https://doi.org/10.1016/j.molcel.2021.08.016

Neugut, A. I., El-Sadr, W. M., & Ruff, P. (2021). The Looming Threat: Cancer in Sub-Saharan Africa. The Oncologist, 26(12), e2099–e2101. https://doi.org/10.1002/onco.13963

DeGroote, N. P., Allen, K. E., Falk, E. E., Velozzi-Averhoff, C., Wasilewski-Masker, K., Johnson, K., & Brock, K. E. (2021). Relationship of race and ethnicity on access, timing, and disparities in pediatric palliative care for children with cancer. Supportive Care in Cancer, 30(1), 923–930. https://doi.org/10.1007/s00520-021-06500-6

Kojadinovic, A., Laderian, B., & Mundi, P. S. (2021). Targeting TRK: A fast-tracked application of precision oncology and future directions. Critical Reviews in Oncology/Hematology, 165, 103451. https://doi.org/10.1016/j.critrevonc.2021.103451